About Valar Labs
Valar Labs is a company based in Palo Alto (United States) founded in 2021 by Pranav Rajpurkar, Anirudh Joshi, Viswesh Krishna, and Damir Vrabac.. Valar Labs has raised $26.15 million across 2 funding rounds from investors including Pear VC, DCVC and Andreessen Horowitz. Valar Labs offers products and services including Vesta and AI Diagnostics. Valar Labs operates in a competitive market with competitors including NEOGAP, Azra, Oncora, Cambridge Cancer Genomics and Cyted, among others.
- Headquarter Palo Alto, United States
- Founders Pranav Rajpurkar, Anirudh Joshi, Viswesh Krishna, Damir Vrabac
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Valar Labs, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.15 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series A
May 30, 2024
-
Investors
Pear VC
& 18 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Valar Labs
Valar Labs offers a comprehensive portfolio of products and services, including Vesta and AI Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts bladder cancer treatment responses using AI on histology.
Provides insights into tumor microenvironments for therapy selection.
Unlock access to complete
Funding Insights of Valar Labs
Valar Labs has successfully raised a total of $26.15M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $22.0M
-
First Round
First Round
(01 Apr 2022)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Valar Labs | Valuation | DCVC , a16z | |
| Apr, 2022 | Amount | Seed - Valar Labs | Valuation | a16z |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Valar Labs
Valar Labs has secured backing from 19 investors, including venture fund and angel investors. Prominent investors backing the company include Pear VC, DCVC and Andreessen Horowitz. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Seed & early stage VC firm investing the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Valar Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Valar Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Valar Labs Comparisons
Competitors of Valar Labs
Valar Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NEOGAP, Azra, Oncora, Cambridge Cancer Genomics and Cyted, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for cancer treatment are developed using advanced technologies.
|
|
| domain | founded_year | HQ Location |
Oncology workflows are automated through AI and machine learning.
|
|
| domain | founded_year | HQ Location |
AI-based clinical data analysis and decision support tool for oncologists
|
|
| domain | founded_year | HQ Location |
Developer of AI-based precision medicine tools for oncologists
|
|
| domain | founded_year | HQ Location |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Valar Labs
When was Valar Labs founded?
Valar Labs was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Valar Labs located?
Valar Labs is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Who is the current CEO of Valar Labs?
Anirudh Joshi is the current CEO of Valar Labs. They have also founded this company.
Is Valar Labs a funded company?
Valar Labs is a funded company, having raised a total of $26.15M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.15M, raised on Apr 01, 2022.
What does Valar Labs do?
Valar Labs was founded in 2021 and is headquartered in Palo Alto, United States. Operations focus on the health technology sector, where AI-driven software is developed to support oncology treatment planning and management. Features include analysis of patient characteristics, data processing, and disease diagnosis assistance for healthcare providers. The tool aids in decision-making processes within clinical settings.
Who are the top competitors of Valar Labs?
Valar Labs's top competitors include NEOGAP, Azra and Cambridge Cancer Genomics.
What products or services does Valar Labs offer?
Valar Labs offers Vesta and AI Diagnostics.
Who are Valar Labs's investors?
Valar Labs has 19 investors. Key investors include Pear VC, DCVC, Andreessen Horowitz, Dave King, and Devin Carty.